According to Ironwood Pharmaceuticals
's latest financial reports the company has -$0.35 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $-0.35 B | -153.08% |
2022-12-31 | $0.65 B | 7.67% |
2021-12-31 | $0.60 B | 867.29% |
2020-12-31 | $62.64 M | -167.17% |
2019-12-31 | $-93.26 M | -52.51% |
2018-12-31 | $-0.2 B | -2094.02% |
2017-12-31 | $9.84 M | -85.24% |
2016-12-31 | $66.71 M | -29.86% |
2015-12-31 | $95.12 M | 7.42% |
2014-12-31 | $88.55 M | 131.66% |
2013-12-31 | $38.22 M | -73.46% |
2012-12-31 | $0.14 B | 31.13% |
2011-12-31 | $0.10 B | -31.15% |
2010-12-31 | $0.15 B | -153.48% |
2009-12-31 | $-0.3 B | 29.48% |
2008-12-31 | $-0.24 B | 29.17% |
2007-12-31 | $-0.18 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
AstraZeneca AZN | $37.50 B | -10,929.21% | ๐ฌ๐ง UK |
Nektar Therapeutics
NKTR | $0.13 B | -137.83% | ๐บ๐ธ USA |